OverviewChartNewsTraderScreen

Soc. Generale Call 42 FRE 20.06.2.../  DE000SW1ESZ0  /

Frankfurt Zert./SG
5/13/2024  9:36:37 PM Chg.+0.001 Bid9:59:32 PM Ask9:59:32 PM Underlying Strike price Expiration date Option type
0.049EUR +2.08% 0.050
Bid Size: 35,000		 0.060
Ask Size: 35,000		 FRESENIUS SE+CO.KGAA... 42.00 - 6/20/2025 Call
GlobeNewswire 4/23 Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire 1/4 Sigyn Therapeutics Releases Letter to Shareholders
GlobeNewswire 11/9/2023 CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
TeleTrader 11/2/2023 Europe opens higher ahead of BoE decision
GlobeNewswire 9/4/2023 CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire 8/31/2023 CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
TeleTrader 7/11/2023 Europe opens mostly higher with data, NATO in focus
TeleTrader 12/23/2022 Europe closes mixed ahead of Christmas
TeleTrader 10/31/2022 Europe closes mostly higher, inflation hits new record
GlobeNewswire 2/25/2022 Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodia...
TeleTrader 2/22/2022 Europe closes mostly lower amid Ukraine worries
GlobeNewswire 2/3/2022 RAYALDEE® Launched in Germany by OPKO Health’s Licensee, VFMCRP
TeleTrader 1/17/2022 Europe opens higher amid the Forum, COVID data
GlobeNewswire 1/5/2022 Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China)
GlobeNewswire 12/31/2021 CIO Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its 15th Y...
GlobeNewswire 12/9/2021 Angion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in Cardiac Surge...
GlobeNewswire 11/22/2021 Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
GlobeNewswire 11/22/2021 Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
GlobeNewswire 11/12/2021 Humacyte Reports Third Quarter 2021 Financial Results and Provides Business Highlights
GlobeNewswire 11/8/2021 Cara Therapeutics Reports Third Quarter 2021 Financial Results
GlobeNewswire 10/27/2021 CIO Leadership: Exemplifying Authentic Leadership and Leveraging Personal Branding to Act as a Globa...
GlobeNewswire 10/26/2021 Angion and Vifor Pharma Report Topline Results from Phase 3 Trial of ANG-3777 in Kidney Transplant P...
GlobeNewswire 9/15/2021 Travere Therapeutics and Vifor Pharma Announce Licensing Agreement for the Commercialization of Spar...
GlobeNewswire 8/26/2021 Humacyte Announces Successful Closing of Business Combination with Alpha Healthcare Acquisition Corp...
GlobeNewswire 8/23/2021 Cara Therapeutics and Vifor Pharma announce U.S. FDA approval of KORSUVA™ (difelikefalin) injection ...